<?xml version='1.0' encoding='utf-8'?>
<document id="27322236"><sentence text="In Vitro Assessment of CYP-Mediated Drug Interactions for Kinsenoside, an Antihyperlipidemic Candidate."><entity charOffset="58-69" id="DDI-PubMed.27322236.s1.e0" text="Kinsenoside" /></sentence><sentence text="Kinsenoside, the herb-derived medicine isolated from the plant Anoect chilus, has diverse pharmacological actions, and it is considered to be a promising antihyperlipidemic drug candidate"><entity charOffset="0-11" id="DDI-PubMed.27322236.s2.e0" text="Kinsenoside" /></sentence><sentence text=" This study evaluates the effects of kinsenoside on CYP enzyme-mediated drug metabolism in order to predict the potential for kinsenoside-drug interactions"><entity charOffset="37-48" id="DDI-PubMed.27322236.s3.e0" text="kinsenoside" /></sentence><sentence text=" Kinsenoside was tested at different concentrations of 0"><entity charOffset="1-12" id="DDI-PubMed.27322236.s4.e0" text="Kinsenoside" /></sentence><sentence text="1, 0" /><sentence text="3, 1, 3, 10, 30, and 100 ÂµM in human liver microsomes" /><sentence text=" The c Cktail probe assay based on liquid chromatography-tandem mass spectrometry was conducted to measure the CYP inhibitory effect of kinsenoside"><entity charOffset="136-147" id="DDI-PubMed.27322236.s7.e0" text="kinsenoside" /></sentence><sentence text=" Subsequently, the metabolism profiles of amlodipine and lovastatin in human liver microsomes were analyzed following co-incubation with kinsenoside"><entity charOffset="42-52" id="DDI-PubMed.27322236.s8.e0" text="amlodipine" /><entity charOffset="57-67" id="DDI-PubMed.27322236.s8.e1" text="lovastatin" /><entity charOffset="137-148" id="DDI-PubMed.27322236.s8.e2" text="kinsenoside" /><pair ddi="false" e1="DDI-PubMed.27322236.s8.e0" e2="DDI-PubMed.27322236.s8.e0" /><pair ddi="false" e1="DDI-PubMed.27322236.s8.e0" e2="DDI-PubMed.27322236.s8.e1" /><pair ddi="false" e1="DDI-PubMed.27322236.s8.e0" e2="DDI-PubMed.27322236.s8.e2" /><pair ddi="false" e1="DDI-PubMed.27322236.s8.e1" e2="DDI-PubMed.27322236.s8.e1" /><pair ddi="false" e1="DDI-PubMed.27322236.s8.e1" e2="DDI-PubMed.27322236.s8.e2" /></sentence><sentence text=" The concentration levels of the parent drug and the major metabolites were compared with the kinsenoside-cotreated samples" /><sentence text=" The effect of kinsenoside was negligible on the enzyme activity of all the CYP isozymes tested even though CYP2A6 was slightly inhibited at higher concentrations"><entity charOffset="15-26" id="DDI-PubMed.27322236.s10.e0" text="kinsenoside" /></sentence><sentence text=" The drug-drug interaction assay also showed that the concomitant use of kinsenoside has a non-significant effect on the concentration of lovastatin or amlodipine, and their major metabolites"><entity charOffset="73-84" id="DDI-PubMed.27322236.s11.e0" text="kinsenoside" /><entity charOffset="138-148" id="DDI-PubMed.27322236.s11.e1" text="lovastatin" /><entity charOffset="152-162" id="DDI-PubMed.27322236.s11.e2" text="amlodipine" /><pair ddi="false" e1="DDI-PubMed.27322236.s11.e0" e2="DDI-PubMed.27322236.s11.e0" /><pair ddi="false" e1="DDI-PubMed.27322236.s11.e0" e2="DDI-PubMed.27322236.s11.e1" /><pair ddi="false" e1="DDI-PubMed.27322236.s11.e0" e2="DDI-PubMed.27322236.s11.e2" /><pair ddi="false" e1="DDI-PubMed.27322236.s11.e1" e2="DDI-PubMed.27322236.s11.e1" /><pair ddi="false" e1="DDI-PubMed.27322236.s11.e1" e2="DDI-PubMed.27322236.s11.e2" /></sentence><sentence text=" So, it was concluded that there is almost no risk of drug interaction between kinsenoside and CYP drug substrates via CYP inhibition" /><sentence text=" " /></document>